Role of stress proteins and hormones in bioregulation of ontogeny
https://doi.org/10.14341/probl201561449-53
Abstract
In this short review article we tried to overview diffusely spread data on the role of stress proteins and hormones in ontogeny. The work presented here is a product of our long-term studies beginning from the middle of eighties of the last century and performed both in Russia and Brazil. It involves the results obtained with the use of experimental models on laboratory animals in vivo and in vitro, as well as later theoretical research in world literature databases. In experimental studies we used laboratory rats of different age groups and primary cultures of pituitary and liver cells for evaluating respectively body and organ growth and production of immunoreactive growth hormone (GH) and serum albumin (SA), as well as biosynthesis of DNA, total RNA and protein. The results obtained, showing important role of glucocorticoids (GC) in regulation of perinatal pituitary and liver functions and postnatal growth, were reinterpreted by us recently in the frame of DOHaD concept and as related to perinatal imprinting/programming phenomena. It is concluded that the present moment is quite appropriate for the widening of our studies both to the side of early embryonal development and in direction to aging, thus completing the whole cycle of life history / course research, as referred to stress proteins and hormones.
References
1. Selye H. A Syndrome produced by Diverse Nocuous Agents. Nature. 1936;138(3479):32-32. doi: 10.1038/138032a0.
2. Kültz D. Evolution of the cellular stress proteome: from monophyletic origin to ubiquitous function. J Exp Biol. 2003;206(18):3119-3124. doi: 10.1242/jeb.00549.
3. Kassahn KS, Crozier RH, Pörtner HO, Caley MJ. Animal performance and stress: responses and tolerance limits at different levels of biological organisation. Biological Reviews. 2009;84(2):277-292. doi: 10.1111/j.1469-185X.2008.00073.x.
4. Goudochnikov VI. [Hormonal mediators and stress proteins: interrelationship in ontogeny and phylogeny]. In: 11. Congresso de Stress da ISMA-BR. Porto Alegre; 2011. (in Portuguese).
5. Christians ES, Zhou Q, Renard J, Benjamin IJ. Heat shock proteins in mammalian development. Semin Cell Dev Biol. 2003;14(5):283-290. doi: 10.1016/j.semcdb.2003.09.021.
6. Akerfelt M, Trouillet D, Mezger V, Sistonen L. Heat Shock Factors at a Crossroad between Stress and Development. Ann N Y Acad Sci. 2007;1113(1):15-27. doi: 10.1196/annals.1391.005.
7. Rappolee DA. Impact of transient stress and stress enzymes on development. Dev Biol. 2007;304(1):1-8. doi: 10.1016/j.ydbio.2006.12.032.
8. Goudochnikov VI. [Stress mediators in pathogeny of age-related diseases]. In: 10. Congresso de Stress da ISMA-BR. Porto Alegre; 2010. (in Portuguese).
9. Baker ME. Steroid receptor phylogeny and vertebrate origins. Mol Cell Endocrinol. 1997;135(2):101-107. doi: 10.1016/s0303-7207(97)00207-4.
10. Ottaviani E, Malagoli D. Around the word stress: its biological and evolutive implications. Invertebrate Survey Journal. 2009;6:1-6.
11. Liggins GC. The role of cortisol in preparing the fetus for birth. Reprod Fertil Dev. 1994;6(2):141. doi: 10.1071/rd9940141.
12. Sloboda D, Challis J, Moss T, Newnham J. Synthetic Glucocorticoids: Antenatal Administration and Long-term Implications. Curr Pharm Des. 2005;11(11):1459-1472. doi: 10.2174/1381612053507873.
13. Федотов В.П., Баранова И.Н., Гудошников В.И. Гормональная регуляция биосинтеза суммарных РНК и белка в культуре клеток печени крыс пре- и постнатального периода развития. // Проблемы эндокринологии. - 1989. - Т. 35. - №3 - С. 54-58. [Fedotov VP, Baranova IN, Gudoshnikov VI. Gormonal’naya regulyatsiya biosinteza summarnykh RNK i belka v kul’ture kletok pecheni krys pre- i postnatal’nogo perioda razvitiya. Probl Endokrinol (Mosk). 1989;35(3):54-58. (in Russ.)].
14. Баранова И.Н., Гудошников В.И., Федотов В.П. Гормональная регуляция продукции сывороточного альбумина культивируемыми гепатоцитами крыс в пре- и постнатальном периоде развития. // Бюллетень экспериментальной биологии и медицины. - 1990. - Т. 109. - №6 - С. 581-583. [Baranova IN, Gudoshnikov VI, Fedotov VP. Gormonal’naya regulyatsiya produktsii syvorotochogo al’bumina kul’tiviruemymi gepatotsitami krys v pre- i postnatal’nom periode razvitiya. Biull Eksp Biol Med. 1990;109(6):581-583. (In Russ.)].
15. Гудошников В.И., Мамаева Т.В., Федотов В.П. Влияние стероидных гормонов и норадреналина на секрецию соматотропного гормона первичными культурами гипофизоцитов крыс различного возраста. // Проблемы эндокринологии. - 1994. - Т. 40. - №1 - С. 39-41. [Gudoshnikov VI, Mamaeva TV, Fedotov VP. Vliyanie steroidnykh gormonov i noradrenalina na sekretsiyu somatotropnogo gormona pervichnymi kul’turami gipofizotsitov krys razlichnogo vozrasta. Probl Endokrinol (Mosk). 1994;40(1):39-41. (In Russ.)].
16. Гудошников В.И., Федотов В.П. Повышенная чувствительность гипофизарных клеток неонатальных крысят к кортикостероидам. // Проблемы эндокринологии. - 1992. - Т. 38. - №1 - С. 61-64. [Gudoshnikov VI, Fedotov VP. Povyshennaya chuvstvitel’nost’ gipofizarnykh kletok neonatal’nykh krysyat k kortikosteroidam. Probl Endokrinol (Mosk). 1992;38(1):61-64. (In Russ.)].
17. Goudochnikov VI, Vaccari SF, Dalmora SL. Pituitary gland may be an important target in the mechanism of growth inhibition after neonatal treatment of rats by glucocorticoid hormone. Neuroendocrinology 1994;60(Suppl.1):59.
18. Goudochnikov VI. [Pathogeny of growth retardation induced by glucocorticoids, as evaluated in experimental studies, using laboratory animals and cellular cultures as the models]. NewsLab (Sao Paulo). 1997;22:90-100. (in Portuguese).
19. Cassol V, Goudochnikov VI. [Growth retardation, without alteration of food consumption, in young rats treated with glucocorticoid in neonatal period]. Revista Contexto & Saude (Ijui). 2001;1(1):113-120. (in Portuguese).
20. Goudochnikov VI. Glucocorticoid programming: prenatal or perinatal? J Develop Orig Health Dis. 2009;1(Suppl.1): S182-S183.
21. Goudochnikov VI. [Disorders in adult state after excessive perinatal exposure to glucocorticoids]. In: 6. Congresso de Stress da ISMA-BR. Porto Alegre; 2006. (in Portuguese).
22. Langley-Evans SC. Developmental programming of health and disease. Proc Nutr Soc. 2007;65(01):97-105. doi: 10.1079/pns2005478.
23. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav. 2011;59(3):279-289. doi: 10.1016/j.yhbeh.2010.06.007.
24. Godfrey KM, Barker DJP. Fetal programming and adult health. Public Health Nutr. 2007;4(2b). doi: 10.1079/phn2001145.
25. De Boo HA, Harding JE. The developmental origins of adult disease (Barker) hypothesis. The Australian and New Zealand Journal of Obstetrics and Gynaecology. 2006;46(1):4-14. doi: 10.1111/j.1479-828X.2006.00506.x.
26. Csaba G. Hormonal imprinting: its role during the evolution and development of hormones and receptors. Cell Biol Int. 2000;24(7):407-414. doi: 10.1006/cbir.2000.0507.
27. Tchernitchin A.N. Perinatal exposure to chemical agents: delayed effects by the mechanism of imprinting (cell programming). ARBS. 2005;7:68-126.
28. Вайсерман А.М. Роль эпигенетических механизмов в раннем “программировании” возраст-зависимых заболеваний. // Пробл. старения и долголетия. - 2008. - Т. 17. - №2 - С. 202-210. [Vaiserman AM. Early-life etiology of age-related diseases: epidemiological study. Problemy stareniia i dolgoletiia. 2008;17(2):202-210. (in Russ.)].
29. Henning SJ. Postnatal development: coordination of feeding, digestion, and metabolism. American Journal of Physiology - Gastrointestinal and Liver Physiology. 1981;241(3):G199-G214.
30. Wada H. Glucocorticoids: Mediators of vertebrate ontogenetic transitions. Gen Comp Endocrinol. 2008;156(3):441-453. doi: 10.1016/j.ygcen.2008.02.004.
31. Нагаева Е.В., Ширяева Т.Ю. «Внутриутробное программирование» гормонально-метаболических процессов и синдром задержки внутриутробного развития. // Проблемы эндокринологии. - 2010. - Т. 56. - №6 - С. 32-40. [Nagaeva EV, Shiriaeva TI. «Intrauterine programming» of hormonal and metabolic processes and intrauterine growth retardation syndrome. Probl Endokrinol (Mosk). 2010;56(6):32-40. (in Russ.)] doi: 10.14341/probl201056632-40.
32. Мельниченко Г.А., Семичева Т.В., Фадеев В.В., Чеботникова Т.В. Применение глюкокортикоидов во время беременности. // Вестник репродуктивного здоровья. - 2008. - №1-2 - С. 7-17. [Mel’nichenko GA, Semicheva TV, Fadeev VV, Chebotnikova TV. Primenenie glyukokortikoidov vo vremya beremennosti. Bulletin of Reproductive Health. 2008; (1-2):7-17.] doi: 10.14341/brh20081-27-17.
33. Сергиенко Л.Ю. Ранний онтогенез - критический период для «программирования» эндокринных и гормонально-зависимых патологий во взрослой жизни. // Клінічна та експериментальна патологія. - 2014. - T. 13. - №3 - С. 224-230. [Sergienko LY. Early ontogeny - critical for period for «programming» endocrint and harmonic dependent pathologies in adult life. Clin and experim pathol. 2014;13(3):224-230. (In Russ.)].
34. Frolkis VV. Aging, Antiaging, Ontogenesis and Periods of Age Development. Gerontology. 1999;45(4):227-232. doi: 10.1159/000022092.
35. Worthman CM, Kuzara J. Life history and the early origins of health differentials. Am J Hum Biol. 2005;17(1):95-112. doi: 10.1002/ajhb.20096.
36. Whalley LJ, Dick FD, McNeill G. A life-course approach to the aetiology of late-onset dementias. The Lancet Neurology. 2006;5(1):87-96. doi: 10.1016/s1474-4422(05)70286-6.
37. Гудошников В.И. Роль гормонов стресса в патогенезе возрастзависимых заболеваний и при старении. // Геронтология и гериатрия. - 2010. - №9 - С. 58-61. [Gudoshnikov VI. Rol’ gormonov stressa v patogeneze vozrastzavisimykh zabolevaniy i pri starenii. Gerontologiya i geriatriya (Moscow) 2010;9:58-61. (In Russ.)].
38. Goudochnikov VI. The role of glucocorticoids in aging and age-related pharmacotherapy. Adv Gerontol. 2011;24(1):48-53.
39. McEwen BS, Seeman T. Protective and Damaging Effects of Mediators of Stress: Elaborating and Testing the Concepts of Allostasis and Allostatic Load. Ann N Y Acad Sci. 1999;896(1):30-47. doi: 10.1111/j.1749-6632.1999.tb08103.x.
40. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;98(8):4770-4775. doi: 10.1073/pnas.081072698.
41. Patel N, Finch C. The glucocorticoid paradox of caloric restriction in slowing brain aging. Neurobiol Aging. 2002;23(5):707-717. doi: 10.1016/s0197-4580(02)00017-9.
42. Rattan SI. Hormesis in aging. Ageing Res Rev. 2008;7(1):63-78. doi: 10.1016/j.arr.2007.03.002.
43. Kroll J. Correlations of plasma cortisol levels, chaperone expression and mammalian longevity: a review of published data. Biogerontology. 2010;11(4):495-499. doi: 10.1007/s10522-010-9264-9.
44. Csermely P. Chaperone overload is a possible contributor to ‘civilization diseases’. Trends Genet. 2001;17(12):701-704. doi: 10.1016/s0168-9525(01)02495-7.
45. Xu Q. Role of Heat Shock Proteins in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2002;22(10):1547-1559. doi: 10.1161/01.atv.0000029720.59649.50.
46. Goudochnikov VI. Comparison of age-related dynamics and gender differences in morbidity and mortality caused by several groups of diseases: no evidence for unique general scheme of aging potentially modifiable by perinatal programming. J. DOHaD. 2009;1(Suppl.1):S123.
47. Goudochnikov VI. Possible contribution of leptin in combination with other hormones to catabolic influence of glucocorticoids. Revista Contexto & Saude (Ijui). 2003;3(5):9-15. (in Portuguese).
48. Goudochnikov VI, Kroth EAF. The role of corticoids in fetal / early programming of metabolic syndrome. Diabetes Clin (Sao Paulo). 2008;12(1):55-59 (in Portuguese).
49. Goudochnikov VI. The importance of hormonal interactions in metabolic regulation. In: 15. Congresso Brasileiro Multidisciplinar Multiprofissional em Diabetes. Sao Paulo: Anad; 2010. p.36. (in Portuguese). © В.И. Гудошников, 2015
Review
For citations:
Goudochnikov V.I. Role of stress proteins and hormones in bioregulation of ontogeny. Problems of Endocrinology. 2015;61(4):49-53. https://doi.org/10.14341/probl201561449-53
Views:
900
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
